Coya Therapeutics, Inc. (COYA) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 19 transactions totaling $3.6K, demonstrating a bullish sentiment with $3.6K in net insider flow. The most recent transaction on Jan 22, 2026 involved a transaction of 293,983 shares valued at $0.
No significant insider buying has been recorded for COYA in the recent period.
No significant insider selling has been recorded for COYA in the recent period.
Based on recent SEC filings, insider sentiment for COYA is bullish with an Insider Alignment Score of 100/100 and a net flow of $3.6K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Coya Therapeutics, Inc. (COYA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading COYA stock, having executed 19 transactions in the past 90 days. The most active insider is Ann Lee (Executive), who has made 4 transactions totaling $29.5K.
Get notified when executives and directors at COYA file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 22, 2026 | Swaminathan Arun | Executive | Award | 293,983 | $N/A | $0 | |
| Jan 22, 2026 | Berman Howard | Executive | Award | 15,257 | $N/A | $0 | |
| Jan 22, 2026 | Grossman Fred | Chief Medical Officer | Award | 140,041 | $N/A | $0 | |
| Jan 22, 2026 | S. Snyder David | Chief Financial Officer | Award | 140,041 | $N/A | $0 | C-Suite |
| Jan 2, 2026 | Lee Ann | Executive | Award | 10,000 | $N/A | $0 | |
| Jan 2, 2026 | L. Ross Wilbur Jr | Executive | Award | 10,000 | $N/A | $0 | |
| Jan 2, 2026 | Weinand Dieter | Executive | Award | 10,000 | $N/A | $0 | |
| Jan 2, 2026 | A. Goldstein Dov Md | Executive | Award | 10,000 | $N/A | $0 | |
| Jan 2, 2026 | Villalobos Anabella | Executive | Award | 10,000 | $N/A | $0 | |
| Aug 18, 2025 | A. Goldstein Dov Md | Executive | Option Exercise | 17,557 | $1.09 | $19.1K | |
| Aug 22, 2023 | Lee Ann | Executive | Purchase | 1,000 | $3.62 | $3.6K | |
| Jan 3, 2023 | A. Goldstein Dov Md | Executive | Purchase | 10,000 | $N/A | $0 | |
| Jan 3, 2023 | Villalobos Anabella | Executive | Purchase | 10,000 | $N/A | $0 | |
| Jan 3, 2023 | S. Snyder David | Executive | Purchase | 7,000 | $N/A | $0 | |
| Jan 3, 2023 | Garren Hideki | Executive | Purchase | 2,000 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Conversion(C) | 1 | $25.9K | 53.2% |
Exercise(M) | 1 | $19.1K | 39.3% |
Purchase(P) | 8 | $3.6K | 7.4% |
Award(A) | 9 | $0 | 0.0% |
Insiders at Coya Therapeutics, Inc. are accumulating shares at an accelerated pace. With 11 insiders making 19 transactions totaling $3.6K in purchases versus $0 in sales, the net buying activity of $3.6K signals strong executive confidence. Ann Lee (Executive) leads the buying activity with $29.5K in transactions across all time.